Soydal, Ç. Et Al. 2021. Prognostic importance of prostatic specific antigen response in patients who received Lutetium-177 prostate-specific membrane antigen treatment for castration resistant prostate cancer. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.65, no.3 , 282-286.

Soydal, Ç., Araz, M., Ürün, Y., Nak, D., Özkan, E., & Küçük, N. Ö., (2021). Prognostic importance of prostatic specific antigen response in patients who received Lutetium-177 prostate-specific membrane antigen treatment for castration resistant prostate cancer. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.65, no.3, 282-286.

Soydal, ÇİĞDEM Et Al. "Prognostic importance of prostatic specific antigen response in patients who received Lutetium-177 prostate-specific membrane antigen treatment for castration resistant prostate cancer," QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.65, no.3, 282-286, 2021

Soydal, ÇİĞDEM Et Al. "Prognostic importance of prostatic specific antigen response in patients who received Lutetium-177 prostate-specific membrane antigen treatment for castration resistant prostate cancer." QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.65, no.3, pp.282-286, 2021

Soydal, Ç. Et Al. (2021) . "Prognostic importance of prostatic specific antigen response in patients who received Lutetium-177 prostate-specific membrane antigen treatment for castration resistant prostate cancer." QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.65, no.3, pp.282-286.

@article{article, author={ÇİĞDEM SOYDAL Et Al. }, title={Prognostic importance of prostatic specific antigen response in patients who received Lutetium-177 prostate-specific membrane antigen treatment for castration resistant prostate cancer}, journal={QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING}, year=2021, pages={282-286} }